REITs have evolved into a larger, more diversified, and better-capitalized asset class, now less sen

CLEVELAND, Sept. 17, 2026 /PRNewswire/ -- The Board of Directors of Preformed Line Products (Nasdaq:

For the past several years, commercial real estate has been treated like the financial equivalent of

Scotiabank analyst Greg McGinniss maintains Lineage (NASDAQ:LINE) with a Sector Perform and lower

NOVI, Mich., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE) (the "Company"), the wo

NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc., (NASDAQ: VALU) reported financial res

Plus, Houthi militants expand control near a strategic Red Sea chokepoint, and the Amazon plane cras

The world's largest cold-storage operator claims negligence caused a massive blaze and is seeking ov

The purchase signals confidence despite the stock price falling over the past 12 months.

LOS ANGELES, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE) today filed a civil law

Lineage (LINE) remains a Buy, with valuation offering a strong margin of safety despite near-term ma

Morgan Stanley analyst Ronald Kamdem upgrades Lineage (NASDAQ:LINE) from Equal-Weight to Overweig

Phase 3 DeLLphi-305 Study Delivered Highly Significant and Clinically Meaningful Overall Survival Be

Wells Fargo analyst Blaine Heck maintains Lineage (NASDAQ:LINE) with a Equal-Weight and raises th

New Program Introduces Flexible Rewards, Status Recognition, Milestone Benefits and More Ways for Gu

BlackRock Inc. bought a new position in shares of Lineage, Inc. (NASDAQ: LINE) during the second qua

Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and lower

BOCA RATON, Fla., Aug. 17, 2026 (GLOBE NEWSWIRE) -- KARMAN LINE ACQUISITION CORP. (the “Company”), a

RBC Capital analyst Michael Carroll maintains Lineage (NASDAQ:LINE) with a Outperform and raises

Citigroup analyst Nick Joseph maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price

Lineage Cell Therapeutics NYSEAMERICAN: LCTX outlined progress across its cell-therapy pipeline duri

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.

Lineage, Inc. (LINE) Q2 2026 Earnings Call Transcript

Lineage NASDAQ: LINE reported second-quarter results that exceeded its internal expectations and con

Although the revenue and EPS for Lineage, Inc. (LINE) give a sense of how its business performed in

Lineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.76 per share, beating

Lineage (NASDAQ:LINE) reported quarterly losses of $(0.13) per share which beat the analyst consensu

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest glob

Analysts upgraded KMX, CAKE, LINE, and WFRD, with price targets raised. Check out their ratings page

Mizuho analyst Vikram Malhotra upgrades Lineage (NASDAQ:LINE) from Neutral to Outperform and rais

Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and raise

UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price

Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:LINE) with a In-Line and raises

Truist Securities analyst Michael Lewis maintains Lineage (NASDAQ:LINE) with a Buy and raises the

Morgan Stanley analyst Ronald Kamdem maintains Lineage (NASDAQ:LINE) with a Equal-Weight and rais

Wells Fargo analyst Blaine Heck maintains Lineage (NASDAQ:LINE) with a Equal-Weight and lowers th

Top Wall Street analysts changed outlook on Adobe, AMD, Campbell's, Lineage, and WR Berkley. See

TSLANVDAMSTRGLDRDDTWARXQQQLINEGOOGLData From https://swaggystocks.com/dashboard/wallstreetbets/ticke

TSLANVDAMSTRRDDTGOOGLLINEWARGLDXJData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-